These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6917563)

  • 21. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.
    Saito H; Goldsmith GH
    Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation of Hageman factor dependent pathways in human disease states.
    Colman RW; Wong PY
    Thromb Haemost; 1977 Dec; 38(4):751-75. PubMed ID: 341410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroform-induced fibrinolysis. Its dependence on Hageman factor, plasma prekallikrein, and high molecular weight kininogen.
    Gordon EM; Ratnoff OD; Goldsmith GH
    J Lab Clin Med; 1980 Apr; 95(4):507-14. PubMed ID: 7359011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors.
    Park S; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Jul; 54(1):11-14. PubMed ID: 34993714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
    Kaplan AP; Meier HL; Mandle RJ
    Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
    [No Abstract]   [Full Text] [Related]  

  • 37. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas.
    Saito H; Goldsmith G; Waldmann R
    Blood; 1976 Dec; 48(6):941-7. PubMed ID: 1000085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.